ESC 2015 Schedule: Difference between revisions
Jump to navigation
Jump to search
Created page with "Monday, August 31, 2015 Tuesday, September 1, 2015" |
No edit summary |
||
Line 1: | Line 1: | ||
Monday, August | |||
Tuesday, | Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red. | ||
Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom | |||
== Click on Date for Detailed Schedule == | |||
== Monday, March 16, 2015 == | |||
=== 8:00 AM === | |||
''OPEN TIME SLOT'' | |||
=== 8:30 AM === | |||
* '''Interviewee:'''Dr. Vivek Reddy | |||
* '''Topic:'''Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial | |||
* '''Embargo Lift:''' Sunday, August 30th at 5:38 PM | |||
=== 9:00 AM === | |||
''OPEN TIME SLOT'' | |||
=== 9:30 AM === | |||
* '''Interviewee: '''Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori) | |||
* '''Topic: '''Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial '''AND '''Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial | |||
* '''Embargo Lift:''' Sunday, August 30th at 4:30 PM''' and''' Sunday, august 30th at 4:30 PM | |||
=== 10:00 AM === | |||
* '''Interviewee:'''Pr. Michel Ovize | |||
* '''Topic:'''Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial | |||
* '''Embargo Lift: '''Sunday, August 30th, at 12:27 PM | |||
=== 10:30 AM ''(PENDING)'' === | |||
* '''Interviewee:'''Dr. Luigi Di Biase | |||
* '''Topic:'''Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF Trial | |||
* '''Embargo Lift:'''Sunday March 15, 2015 at 9:00AM | |||
=== 11:00 AM === | |||
* '''Interviewee:'''Dr. Marc Gillinov | |||
* '''Topic:'''Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network | |||
* '''Embargo Lift:'''Monday March 16, 2015 at 8:15AM | |||
=== 11:30 AM === | |||
* '''Interviewee:'''Dr. Rajeev K. Pathak | |||
* '''Topic:'''Long-Term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study) | |||
* '''Embargo Lift:'''Monday March 16, 2015 at 8:30AM | |||
=== 12:00 PM === | |||
=== 12:30 PM === | |||
* '''Interviewee:'''Dr. Rino Sardella | |||
* '''Topic:'''ACC 2015 Wrap-Up in Italian | |||
=== 1:00 PM === | |||
* '''Interviewee:'''Dr. Hisao Ogawa | |||
* '''Topic:'''ACC 2015 Wrap-Up in Japanese | |||
=== 1:30 PM === | |||
* '''Interviewee:'''Dr. Susheel Kodali | |||
* '''Topic:'''Early Clinical and Echocardiographic Outcomes with the SAPIEN 3 Transcatheter Aortic Valve Replacement System in Inoperable, High-Risk and Intermediate-Risk Aortic Stenosis Patients | |||
* '''Embargo Lift:'''Sunday March 15, 2015 at 11:15AM | |||
=== 2:00 PM === | |||
=== 2:30 PM === | |||
* '''Interviewee:'''Dr. Pamela S. Douglas | |||
* '''Topic:'''A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease: Results from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain) | |||
* '''Embargo Lift:'''Saturday March 14, 2015 at 9:05AM | |||
=== 3:00 PM === | |||
* '''Interviewee:'''Dr. Marco Valgimigli | |||
* '''Topic:'''Transradial Versus Transfemoral Access In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Access Site Program'''&'''Bivalirudin Infusion Compared To Unfractionated Heparin In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Anti-thrombin Program | |||
* '''Embargo Lift:'''Monday March 16, 2015 at 11:00AM'''&'''Monday March 16, 2015 at 11:15AM, respectively | |||
=== 3:30 PM === | |||
* '''Interviewee:'''Dr. Marc Steven Sabatine | |||
* '''Topic:'''Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) - Thrombolysis in Myocardial Infarction (TIMI) 54 & Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes | |||
* '''Embargo Lift:'''Saturday March 14, 2015 at 9:30AM & Sunday March 15, 2015 at 8:00AM, respectively | |||
=== 4:00 PM === | |||
* '''Interviewee:'''Dr. Roxana Mehran | |||
* '''Topic:'''A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention | |||
* '''Embargo Lift:'''Sunday March 15, 2015 at 8:30AM | |||
=== 4:30 PM === | |||
* '''Interviewee:'''Dr. Thomas Engstrøm | |||
* '''Topic:'''The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: PRImary PCI in MULTIvessel Disease | |||
* '''Embargo Lift:'''Monday March 16, 2015 at 11:30AM | |||
=== 5:00 PM === | |||
* '''Interviewee:'''Prof. Dr. Sigmund Silber | |||
* '''Topic:'''ACC 2015 Wrap-Up in German | |||
== Tuesday, March 17, 2015 == | |||
=== 8:00 AM === | |||
=== 8:30 AM === | |||
=== 9:00 AM === | |||
=== 9:30 AM === | |||
=== 10:00 AM === | |||
=== 10:30 AM === | |||
=== 11:00 AM === | |||
=== 11:30 AM === | |||
=== 12:00 PM === | |||
=== 12:30 PM === | |||
=== 1:00 PM === | |||
=== 1:30 PM === | |||
=== 2:00 PM === | |||
=== 2:30 PM === | |||
=== 3:00 PM === | |||
=== 3:30 PM === | |||
=== 4:00 PM === | |||
=== 4:30 PM === |
Revision as of 15:25, 9 July 2015
Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.
Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom
Click on Date for Detailed Schedule
Monday, March 16, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
- Interviewee:Dr. Vivek Reddy
- Topic:Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
- Embargo Lift: Sunday, August 30th at 5:38 PM
9:00 AM
OPEN TIME SLOT
9:30 AM
- Interviewee: Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
- Topic: Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial AND Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
- Embargo Lift: Sunday, August 30th at 4:30 PM and Sunday, august 30th at 4:30 PM
10:00 AM
- Interviewee:Pr. Michel Ovize
- Topic:Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
- Embargo Lift: Sunday, August 30th, at 12:27 PM
10:30 AM (PENDING)
- Interviewee:Dr. Luigi Di Biase
- Topic:Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF Trial
- Embargo Lift:Sunday March 15, 2015 at 9:00AM
11:00 AM
- Interviewee:Dr. Marc Gillinov
- Topic:Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network
- Embargo Lift:Monday March 16, 2015 at 8:15AM
11:30 AM
- Interviewee:Dr. Rajeev K. Pathak
- Topic:Long-Term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study)
- Embargo Lift:Monday March 16, 2015 at 8:30AM
12:00 PM
12:30 PM
- Interviewee:Dr. Rino Sardella
- Topic:ACC 2015 Wrap-Up in Italian
1:00 PM
- Interviewee:Dr. Hisao Ogawa
- Topic:ACC 2015 Wrap-Up in Japanese
1:30 PM
- Interviewee:Dr. Susheel Kodali
- Topic:Early Clinical and Echocardiographic Outcomes with the SAPIEN 3 Transcatheter Aortic Valve Replacement System in Inoperable, High-Risk and Intermediate-Risk Aortic Stenosis Patients
- Embargo Lift:Sunday March 15, 2015 at 11:15AM
2:00 PM
2:30 PM
- Interviewee:Dr. Pamela S. Douglas
- Topic:A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease: Results from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain)
- Embargo Lift:Saturday March 14, 2015 at 9:05AM
3:00 PM
- Interviewee:Dr. Marco Valgimigli
- Topic:Transradial Versus Transfemoral Access In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Access Site Program&Bivalirudin Infusion Compared To Unfractionated Heparin In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Anti-thrombin Program
- Embargo Lift:Monday March 16, 2015 at 11:00AM&Monday March 16, 2015 at 11:15AM, respectively
3:30 PM
- Interviewee:Dr. Marc Steven Sabatine
- Topic:Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) - Thrombolysis in Myocardial Infarction (TIMI) 54 & Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes
- Embargo Lift:Saturday March 14, 2015 at 9:30AM & Sunday March 15, 2015 at 8:00AM, respectively
4:00 PM
- Interviewee:Dr. Roxana Mehran
- Topic:A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention
- Embargo Lift:Sunday March 15, 2015 at 8:30AM
4:30 PM
- Interviewee:Dr. Thomas Engstrøm
- Topic:The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: PRImary PCI in MULTIvessel Disease
- Embargo Lift:Monday March 16, 2015 at 11:30AM
5:00 PM
- Interviewee:Prof. Dr. Sigmund Silber
- Topic:ACC 2015 Wrap-Up in German